A pharmacoepidemiological study of rivaroxaban use and potential adverse outcomes in routine clinical practice in Sweden

Data sources

• Data source(s):
  National Prescribed Drugs Register / Läkemedelsregistret
• Data source(s), other:
  National Swedish Drug Register Sweden, National Swedish Patient Register Sweden, National Cause of Death Register Sweden, Swedish LISA (Longitudinal integration database for health insurance and labour market studies) database
• Data sources (types):
  Administrative data (e.g. claims)

  Drug dispensing/prescription data

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No